I agree, lowering prices is not a crime. Aren't they also using their market clout to write deals that don't allow their competitors? I didn't read TFA, but that is what I took this sentence to mean: " Some deals require pharmacies to reject prescriptions for low-cost generics and substitute a discounted name-brand Lipitor while other deals block generic makers from mail-order services that account for an estimated 40 percent of all Lipitor prescriptions."
Lowering prices, good, fair, fine. Anti-competitive deals, not so much.
Why the quote from David A. Balto is so lame, who knows. Again I didn't read THA.